What does BIOCLIN CONSULTING & MARKETING do?

BIOCLIN CONSULTING & MARKETING is a healthcare practice in Sint-Pieters-Leeuw. Private Limited, started on 2 October 2001, 1 establishment.

What is the address of BIOCLIN CONSULTING & MARKETING?

The registered office of BIOCLIN CONSULTING & MARKETING is located at Meerweg 119, 1601 Sint-Pieters-Leeuw.

Is BIOCLIN CONSULTING & MARKETING still active?

Yes. According to the CBE (16 September 2026) BIOCLIN CONSULTING & MARKETING is active, legal situation “Normale toestand”, started on 2 October 2001.

Is BIOCLIN CONSULTING & MARKETING registered on Peppol?

Yes, BIOCLIN CONSULTING & MARKETING is registered on the Peppol network with ID 0208:0475753623.

What is the enterprise number of BIOCLIN CONSULTING & MARKETING?

The enterprise number of BIOCLIN CONSULTING & MARKETING is BE0475753623.

When was BIOCLIN CONSULTING & MARKETING founded?

BIOCLIN CONSULTING & MARKETING was founded on 2 October 2001.

Is BIOCLIN CONSULTING & MARKETING a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 October 2001; 4 annual accounts filed, latest fiscal year 2024.

How much profit did BIOCLIN CONSULTING & MARKETING make in 2024?

BIOCLIN CONSULTING & MARKETING posted a profit after taxes of € 23,179 in financial year 2024.

What is the revenue of BIOCLIN CONSULTING & MARKETING?

In its most recent annual accounts (2024), BIOCLIN CONSULTING & MARKETING reported revenue of € 222,095.

BIOCLIN CONSULTING & MARKETING (Private Limited)

Dossier BIOCLIN CONSULTING & MARKETING, printed on 16 September 2026 from databakkes.be/en/0475753623/bioclin-consulting-marketing. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

BIOCLIN CONSULTING & MARKETING from Sint-Pieters-Leeuw, company number BE0475753623, closed financial year 2024 with a result of € 23,179 after tax. For that financial year BIOCLIN CONSULTING & MARKETING recorded revenue of € 222,095 and equity of € 61,182. Compared with financial year 2023, the result moved from € 2,727 to € 23,179. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 17, 2025.

What it is worth Healthy

€ 61,182

▼ 1% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 23,179

▲ € 20,452 vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 108,609

▲ € 91,997 vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 24,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2024

Vehicles and equipment

€ 7,514

▲ 30% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 118,640

€ 28,836 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 47,026

▲ 139% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 550

▼ 80% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Revenue	€ 205,750 Revenue 2021: € 205,750 First fiscal year in the series	€ 207,160 Revenue 2022: € 207,160 ▲ 1% vs 2021 (€ 205,750) Favourable step	€ 222,065 Revenue 2023: € 222,065 ▲ 7% vs 2022 (€ 207,160) Favourable step	€ 222,095 Revenue 2024: € 222,095 Unchanged (€ 222,065) Favourable step
Gross margin	€ 8,919 Gross margin 2021: € 8,919 First fiscal year in the series	€ 4,123 Gross margin 2022: € 4,123 ▼ 54% vs 2021 (€ 8,919) Unfavourable step	€ 10,488 Gross margin 2023: € 10,488 ▲ 154% vs 2022 (€ 4,123) Favourable step	€ 39,220 Gross margin 2024: € 39,220 ▲ 274% vs 2023 (€ 10,488) Favourable step	▲ 274%
Profit after taxes	€ 2,895 Profit after taxes 2021: € 2,895 First fiscal year in the series	€ -508 Profit after taxes 2022: € -508 ▼ € 3,403 vs 2021 (€ 2,895) Unfavourable step	€ 2,727 Profit after taxes 2023: € 2,727 ▲ € 3,235 vs 2022 (€ -508) Favourable step	€ 23,179 Profit after taxes 2024: € 23,179 ▲ € 20,452 vs 2023 (€ 2,727) Favourable step	▲ € 20,452
Equity	€ 59,784 Equity 2021: € 59,784 First fiscal year in the series	€ 59,276 Equity 2022: € 59,276 ▼ 1% vs 2021 (€ 59,784) Unfavourable step	€ 62,003 Equity 2023: € 62,003 ▲ 5% vs 2022 (€ 59,276) Favourable step	€ 61,182 Equity 2024: € 61,182 ▼ 1% vs 2023 (€ 62,003) Unfavourable step	▼ 1%
Total debts	€ 51,090 Total debts 2021: € 51,090 First fiscal year in the series	€ 46,011 Total debts 2022: € 46,011 ▼ 10% vs 2021 (€ 51,090) Favourable step	€ 53,727 Total debts 2023: € 53,727 ▲ 17% vs 2022 (€ 46,011) Unfavourable step	€ 190,216 Total debts 2024: € 190,216 ▲ 254% vs 2023 (€ 53,727) Unfavourable step	▲ 254%
Cash	€ 6,843 Cash 2021: € 6,843 First fiscal year in the series	€ 4,303 Cash 2022: € 4,303 ▼ 37% vs 2021 (€ 6,843) Unfavourable step	€ 16,612 Cash 2023: € 16,612 ▲ 286% vs 2022 (€ 4,303) Favourable step	€ 108,609 Cash 2024: € 108,609 ▲ € 91,997 vs 2023 (€ 16,612) Favourable step	▲ € 91,997
Retained profit	€ 41,184 Retained profit 2021: € 41,184 First fiscal year in the series	€ 40,676 Retained profit 2022: € 40,676 ▼ 1% vs 2021 (€ 41,184) Unfavourable step	€ 43,403 Retained profit 2023: € 43,403 ▲ 7% vs 2022 (€ 40,676) Favourable step	€ 40,722 Retained profit 2024: € 40,722 ▼ 6% vs 2023 (€ 43,403) Unfavourable step	▼ 6%
Dividend	€ 12,000 Dividend 2021: € 12,000 First fiscal year in the series	€ 0 Dividend 2022: € 0 ▼ 100% vs 2021 (€ 12,000) Unchanged	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 24,000 Dividend 2024: € 24,000 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2021: € 0 First fiscal year in the series	€ 0 Bank debt 2022: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 118,640 Bank debt 2024: € 118,640 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 110,874 Balance sheet total 2021: € 110,874 First fiscal year in the series	€ 105,287 Balance sheet total 2022: € 105,287 ▼ 5% vs 2021 (€ 110,874) Unchanged	€ 115,730 Balance sheet total 2023: € 115,730 ▲ 10% vs 2022 (€ 105,287) Unchanged	€ 251,398 Balance sheet total 2024: € 251,398 ▲ 117% vs 2023 (€ 115,730) Unchanged	▲ 117%

Key figures of BIOCLIN CONSULTING & MARKETING, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to BIOCLIN CONSULTING & MARKETING?

What happened at BIOCLIN CONSULTING & MARKETING in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 17, 2025 New annual accounts for financial year 2024: profit of € 23,179 (▲ € 20,452 vs 2023). filed late Source: NBB ↗
Jan 28, 2002 New establishment in Sint-Pieters-Leeuw. KBO
Oct 2, 2001 Start of the company according to the CBE. KBO

In short

From € 2,895 profit in 2021 to € 23,179 profit in 2024.

Paid € 5,574 in corporate taxes since 2021.

Best year ever: 2024, with € 23,179 profit.

Paid out € 36,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at BIOCLIN CONSULTING & MARKETING? We notify you, reason included.

Follow BIOCLIN CONSULTING & MARKETING

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Establishments

Establishment units

Physical locations of this company

Registered office

Meerweg 119

1601 Sint-Pieters-Leeuw

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0475.753.623

VAT number

BE 0475.753.623

Registered office

Meerweg 119, 1601 Sint-Pieters-Leeuw

Names & denominations

BIOCLIN CONSULTING & MARKETING

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

2 October 2001

Peppol

Active · Active since 14 Jan 2026

Activities · NACE

Activiteiten op het gebied van voeding

Overige activiteiten i.v.m. gezondheidszorg, n.e.g.

Overige menselijke gezondheidszorg, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗